SVNT (Savient Pharmaceu)
All Pro Portfolios with SVNT
  • 1
  •     
  •  

People owning SVNT also tend to own:: DFJNPRORCLRVBDTOFTSCMYHOO

All Do-It-Yourself Portfolios with SVNT
  • News For Selected Stock
  • Related stories on theStreet.com
  • videos related to etf's
  • No videos found
  •  
  • blogs related to etf's
  • No blogs found
  •  

Why I Love This Stock

By:amcutler

Date:07 28 09

spec up over 100%

Not yet rated
Rate now:

By:Trading Nymph

Date:12 30 08

4

Not yet rated
Rate now:

By:mr1kimcpa

Date:04 10 08

long term

Not yet rated
Rate now:

By:Pro

Date:11 30 -1

Savient Pharma (SVNT) was upgraded from Neutral to Buy, Merrill Lynch said. $28 price target. Believe that positive Phase III data will lead to FDA approval for Puricase.

Not yet rated
Rate now:

By:Jacques Lemoyne

Date:11 04 07

New gout medication testing seems to be thumbs up. Only one of its kind. Should go on the market next year.

Not yet rated
Rate now:

By:goodferry

Date:10 08 07

Cramer

Not yet rated
Rate now:

By:TomK

Date:09 27 07

Have been buying dips since December 06. Learned about it via Cramer video. It's all about the Phase III trial being successful. I love it because its easy to know to buy the dips as long as there is no bad news about the Phase III trial.

Not yet rated
Rate now:

By:Norm Ajesty

Date:09 22 07

own

Not yet rated
Rate now:

By:bilken

Date:07 28 07

on technical

Not yet rated
Rate now:

By:Uncle Richard

Date:07 27 07

mm

Not yet rated
Rate now:

Why I Hate This Stock

By:LadyMoneyMagnet

Date:07 03 07

LOST MONEY

Not yet rated
Rate now:

By:Andrea2

Date:01 12 07

If you look at the details of this highly touted gout drug, Puricase, it's not impressive. It's administered as a 2h IV infusion every two weeks and is only indicated for patients have haven't responded to any other therapy. That doesn't sound like a big market to me. Puricase is just a pegylated protein, this is not innovative science.

Not yet rated
Rate now:
Add Your Comments  
Stock SVNT
Allowed HTML tags: <a><b><i><img>
  Login to post your comments
Squeezing the Shorts: Large-Cap ...

By Jonas Elmerraji Posted on Nov. 11, 2009 Recently we put our short-squeeze focus on smaller stocks; this week we’re going large-cap. With higher trading volumes, mo...

11.11.09 | 15:19 PM
Dividend Stocks for the Week

By Jonas Elmerraji Posted on Nov. 10, 2009 After six straight days of gains, the markets are taking a breather today, which gives us the chance to focus our attention b...

11.10.09 | 15:04 PM
This Week's 'Barron's' Roundup

By Roberto Pedone Posted on Nov. 9, 2009 Financial-Services Bull: Barron’s talks with Anton Schutz, portfolio manager at the Burnham Financial Industries Fund (BURFX)...

11.09.09 | 11:01 AM
Rocket Stocks for the Week

By Jonas Elmerraji Posted on Nov. 9, 2009 Last week brought investors a welcome return to gains as the S&P 500 pushed up 3.2% over the course of the last five trading d...

11.09.09 | 08:04 AM
more articles
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
Banjo's Garden Pic Thread
05.10.09 | 12:33 PM From author banjoman
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
Wealth distribution by race and ...
11.23.08 | 18:44 PM From author Valerie J
more forums
Q. Mr. Cramer, Could you explain t...
11.11.09 | 20:10 PM Asked by kenandkristin

A. because he's not about making friends,
he's about making money...and if you
really follow cramer then you'd a done
your homework and should know how to
play this. which those who don't do
their homework provide opportunities for
those who do.

today 's lists
Stocks With Unusual Option Activity

Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more

52-Week Lows

Here is a list of some of the biggest stocks that hit 52-week lows on Nov. 2, 2009. more

Rising on Unusual Volume

Here are some stocks that moved up on unusual volume on Nov. 2, 2009. more